⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BMY

Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General

64.41USD

-0.2800 (-0.43%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.73▲$1.6161
Next quarter$1.59▲$1.53153
Current year$6.95▲$6.31250
Next year$6.56▲$6.17242

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.6$2.04+0.44 (+27.7%)
2026-03-31$1.42$1.58+0.16 (+11.2%)
2025-12-31$1.2$1.26+0.06 (+4.6%)
2025-09-30$1.52$1.63+0.11 (+7.6%)

Wall Street coverage

297 ratings from 39 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Argus ResearchUpgraded from HoldBuy$75Aug 5, 2026
CitigroupMaintainedNeutral$66 $70Aug 3, 2026
RBC CapitalMaintainedSector Perform$60 $64Jul 31, 2026
JP MorganMaintainedOverweight$67 $73Jul 31, 2026
Cantor FitzgeraldMaintainedNeutral$54 $59Jul 31, 2026
Wells FargoMaintainedEqual-Weight$60 $65Jul 31, 2026
GuggenheimMaintainedBuy$72 $75Jul 31, 2026
Truist SecuritiesReiteratedBuy$65 $70Jul 31, 2026
B of A SecuritiesMaintainedBuy$67 $66Jul 10, 2026
Cantor FitzgeraldReiteratedNeutral$54Jul 6, 2026
B of A SecuritiesMaintainedBuy$68 $67Apr 9, 2026
GuggenheimReiteratedBuy$72Apr 8, 2026
Cantor FitzgeraldMaintainedNeutral$45 $54Apr 8, 2026
HSBCMaintainedHold$53 $60Mar 17, 2026
RBC CapitalInitiatedSector Perform$60Feb 25, 2026
Piper SandlerMaintainedOverweight$66 $75Feb 23, 2026
BarclaysInitiatedOverweight$75Feb 20, 2026
CitigroupMaintainedNeutral$60 $64Feb 6, 2026
Wells FargoMaintainedEqual-Weight$55 $60Feb 6, 2026
GuggenheimMaintainedBuy$62 $72Feb 6, 2026
Piper SandlerMaintainedOverweight$62 $66Jan 28, 2026
CitigroupMaintainedNeutral$53 $60Jan 27, 2026
Leerink PartnersMaintainedOutperform$54 $60Jan 13, 2026
ScotiabankMaintainedSector Perform$53 $60Jan 9, 2026
CitigroupMaintainedNeutral$45 $53Jan 7, 2026

Insider transactions

60 filings from 17 insiders · 18 buy / 2 sell over 6m

Officers and directors of BMY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Short Bartie WendyOfficer, EVP, Corporate AffairsExerciseRestricted Stock Units1.2k——Sep 1, 2026
Short Bartie WendyOfficer, EVP, Corporate AffairsTax633$66.92$42kSep 1, 2026
Short Bartie WendyOfficer, EVP, Corporate AffairsExercise1.2k$66.92$83kSep 1, 2026
HOLZER PHIL MOfficerSell500$67.50$34kAug 25, 2026
GALLMAN CARIGeneral CounselOther1.1k——Jul 31, 2026
MASSACESI CRISTIANOfficerOther51.2k——Jul 31, 2026
HALLER JULIA ADirectorExercise20.5k$53.76$1.10MJun 15, 2026
SHORT BARTIE WENDYOfficerOther8.0k——Jun 3, 2026
LENKOWSKY ADAMOfficerOther1.4k——May 1, 2026
SHANAHAN KARINOfficerOther3.3k——Apr 1, 2026
ELKINS DAVID VINCENTChief Financial OfficerSell30.0k$61.60$1.85MApr 1, 2026
GALLMAN CARIGeneral CounselOther7.0k——Mar 10, 2026
HOCH LYNELLE BAUMGARDNEROfficerOther8.2k——Mar 10, 2026
POOLE AHN AMANDAOfficerOther6.4k——Mar 10, 2026
HOLZER PHIL MOfficerOther6.2k——Mar 10, 2026
SHORT BARTIE WENDYOfficerOther5.9k——Mar 10, 2026
MEYERS GREGORY SCOTTChief Technology OfficerOther25.9k——Mar 10, 2026
SHANAHAN KARINOfficerOther25.5k——Mar 10, 2026
LENKOWSKY ADAMOfficerOther24.1k——Mar 10, 2026
BOERNER CHRISTOPHER SChief Executive OfficerOther71.5k——Mar 10, 2026

Analyst Notes

Sign in to write

No analyst notes on BMY yet.

Analyst Ratings

24 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current371710Hold2.57
1 mo ago371710Hold2.57
2 mo ago361810Hold2.61
3 mo ago461710Hold2.54
Price target$66.21$40.00 – $80.00
+2.8% to target